Secukinumab dose escalation on ACR responses in anti-tumour necrosis factor naïve patients with psoriatic arthritis: 2-year data from the phase 3 Future 4 and Future 5 studies

P Emery; Mikkel Østergaard; LC Coates; A Deodhar; E Quebe-Fehling; P Pellet; L Pricop; C Gaillez; F Van den Bosch

Secukinumab dose escalation on ACR responses in anti-tumour necrosis factor naïve patients with psoriatic arthritis: 2-year data from the phase 3 Future 4 and Future 5 studies

P Emery, Mikkel Østergaard, LC Coates, A Deodhar, E Quebe-Fehling, P Pellet, L Pricop, C Gaillez, F Van den Bosch

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Dansk
Artikelnummer	THU0373
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	79
Udgave nummer	Suppl. 1
Sider (fra-til)	418-419
Antal sider	2
ISSN	0003-4967
Status	Udgivet - 2020

Citationsformater

Emery, P., Østergaard, M., Coates, LC., Deodhar, A., Quebe-Fehling, E., Pellet, P., Pricop, L., Gaillez, C., & Van den Bosch, F. (2020). Secukinumab dose escalation on ACR responses in anti-tumour necrosis factor naïve patients with psoriatic arthritis: 2-year data from the phase 3 Future 4 and Future 5 studies. Annals of the Rheumatic Diseases, 79(Suppl. 1), 418-419. [THU0373].

Secukinumab dose escalation on ACR responses in anti-tumour necrosis factor naïve patients with psoriatic arthritis: 2-year data from the phase 3 Future 4 and Future 5 studies. / Emery, P; Østergaard, Mikkel; Coates, LC et al.

I: Annals of the Rheumatic Diseases, Bind 79, Nr. Suppl. 1, THU0373, 2020, s. 418-419.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Emery, P, Østergaard, M, Coates, LC, Deodhar, A, Quebe-Fehling, E, Pellet, P, Pricop, L, Gaillez, C & Van den Bosch, F 2020, 'Secukinumab dose escalation on ACR responses in anti-tumour necrosis factor naïve patients with psoriatic arthritis: 2-year data from the phase 3 Future 4 and Future 5 studies', Annals of the Rheumatic Diseases, bind 79, nr. Suppl. 1, THU0373, s. 418-419.

@article{e6a2eb7e5f0a4c27a93e64e2a6763d73,

title = "Secukinumab dose escalation on ACR responses in anti-tumour necrosis factor na{\"i}ve patients with psoriatic arthritis: 2-year data from the phase 3 Future 4 and Future 5 studies",

author = "P Emery and Mikkel {\O}stergaard and LC Coates and A Deodhar and E Quebe-Fehling and P Pellet and L Pricop and C Gaillez and {Van den Bosch}, F",

note = "COPECARE",

year = "2020",

language = "Dansk",

volume = "79",

pages = "418--419",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

}

TY - ABST

T1 - Secukinumab dose escalation on ACR responses in anti-tumour necrosis factor naïve patients with psoriatic arthritis: 2-year data from the phase 3 Future 4 and Future 5 studies

AU - Emery, P

AU - Østergaard, Mikkel

AU - Coates, LC

AU - Deodhar, A

AU - Quebe-Fehling, E

AU - Pellet, P

AU - Pricop, L

AU - Gaillez, C

AU - Van den Bosch, F

N1 - COPECARE

PY - 2020

Y1 - 2020

M3 - Konferenceabstrakt i tidsskrift

VL - 79

SP - 418

EP - 419

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl. 1

M1 - THU0373

ER -